BlackRock Inc. Has $1.52 Billion Stake in Healthpeak Properties, Inc. $DOC

Key Points

• BlackRock trimmed its Healthpeak Properties stake by 3.3% in the second quarter, selling 2.43 million shares but retaining 70.94 million shares valued at approximately $1.52 billion, or 10.29% of the company.
• Analysts remain cautious, with a consensus “Hold” rating and an average price target of $21.66. Four analysts rate the stock a Buy, while 14 recommend holding it.
• Healthpeak exceeded quarterly expectations with adjusted EPS of $0.08 versus the $0.03 consensus and revenue of $771.6 million, up 11.1% year over year. The REIT also declared a monthly dividend of $0.1017 per share, representing a stated 5.7% yield.

BlackRock Inc. trimmed its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 3.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 70,935,046 shares of the real estate investment trust's stock after selling 2,425,473 shares during the period. BlackRock Inc. owned approximately 10.29% of Healthpeak Properties worth $1,518,010,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. OneDigital Investment Advisors LLC raised its position in Healthpeak Properties by 3.3% in the 2nd quarter. OneDigital Investment Advisors LLC now owns 15,376 shares of the real estate investment trust's stock worth $329,000 after purchasing an additional 493 shares during the last quarter. Clearstead Trust LLC boosted its position in Healthpeak Properties by 66.7% in the 2nd quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust's stock valued at $29,000 after buying an additional 543 shares during the last quarter. CX Institutional boosted its position in Healthpeak Properties by 6.1% in the 2nd quarter. CX Institutional now owns 11,003 shares of the real estate investment trust's stock valued at $235,000 after buying an additional 633 shares during the last quarter. Fiduciary Trust Co increased its stake in shares of Healthpeak Properties by 4.9% in the 3rd quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust's stock valued at $264,000 after buying an additional 644 shares during the period. Finally, Quadrant Capital Group LLC increased its stake in shares of Healthpeak Properties by 1.9% in the 3rd quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust's stock valued at $721,000 after buying an additional 718 shares during the period. 93.57% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

DOC has been the topic of a number of research reports. Cantor Fitzgerald upped their target price on shares of Healthpeak Properties from $20.00 to $23.00 and gave the company a "neutral" rating in a research report on Thursday, August 6th. Morgan Stanley reissued an "equal weight" rating and set a $22.00 price target (up from $20.00) on shares of Healthpeak Properties in a research note on Thursday, June 11th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Healthpeak Properties in a report on Wednesday, August 5th. Scotiabank upped their target price on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company a "sector perform" rating in a research report on Wednesday, May 27th. Finally, Barclays started coverage on Healthpeak Properties in a research note on Tuesday, July 7th. They issued an "equal weight" rating and a $23.00 price target on the stock. Four analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $21.66.

Healthpeak Properties Stock Performance

Shares of DOC stock opened at $21.24 on Friday. Healthpeak Properties, Inc. has a 52 week low of $15.70 and a 52 week high of $22.95. The company has a market capitalization of $14.65 billion, a price-to-earnings ratio of 60.69, a PEG ratio of 3.20 and a beta of 1.01. The company has a 50-day simple moving average of $21.37 and a 200 day simple moving average of $19.00. The company has a debt-to-equity ratio of 1.06, a quick ratio of 3.02 and a current ratio of 3.02.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, beating analysts' consensus estimates of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.The business had revenue of $771.58 million during the quarter, compared to the consensus estimate of $725.64 million. During the same quarter in the previous year, the firm earned $0.46 earnings per share. Healthpeak Properties's revenue for the quarter was up 11.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. On average, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be paid a $0.1017 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) annualized dividend and a yield of 5.7%. Healthpeak Properties's payout ratio is 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source